Donor Screening

One-third of the blood and plasma donated worldwide in 2015 was screened for infectious diseases using blood safety solutions from Roche.¹

For organizations facing the critical challenge of ensuring safe blood supplies, Roche offers a comprehensive screening solution. Pre-analytics and IT, and nucleic acid testing (NAT) are all available from a single source.

Keeping the blood supply safe

Blood is a crucial healthcare resource and can save lives. Every year worldwide there are over 164 million blood and plasma donations that are commonly used in supportive care for cardiovascular and transplant surgery patients, trauma victims, and those undergoing cancer therapy.^2,3 Ensuring access to a sufficient and safe supply of blood and blood-derived products is an international health priority that has been highlighted by the World Health Organization since 1975.⁴ Roche is a trusted partner for screening centers.

One blood donation has the potential to save 3 lives⁵

Blood transfusion safety relies heavily on the accurate and timely screening of blood for transmissible infections. In addition, pathogens evolve and new ones emerge, demanding the need for continuous and robust test innovation and development.

With over 30 years in blood safety, Roche offers the most comprehensive screening solution on the market today.⁶ Roche has become a trusted partner for screening centers, and is the only single provider for Nucleic Acid Testing (NAT), Lab Automation and IT for blood centers and blood fractionators worldwide.⁶

Achieve the maximum efficiency that only Roche can offer. Each Roche solution works together throughout every step of your blood screening workflow, including pre-analytics, and nucleic acid testing. 

The IT solutions intelligently link every part of your workflow, from routing samples and dynamically monitoring production, to making it simple to adjust workflows for maximum productivity.